Literature DB >> 34662926

Comparison of extraperitoneal laparoscopic and extraperitoneal Senhance radical prostatectomy.

Tomislav Kulis1,2, Tvrtko Hudolin1,2, Luka Penezic1, Toni Zekulic1, Hrvoje Saic1, Nikola Knezevic1,2, Zeljko Kastelan1,2.   

Abstract

BACKGROUND: Senhance is novel robotic platform which can be used to perform radical prostatectomy (RP). We compare our results of robotic RP to similar patients operated with laparoscopic technique. PATIENTS AND METHODS: A prospective study of 61 patients operated laparoscopically and 107 patients operated using the Senhance robotic system. We have analysed operative and postoperative results in both groups.
RESULTS: There was no difference in the operative time, estimated blood loss, positive surgical margins, length of hospitalisation and catheterisation. There were 4 (6.5%) Clavien-Dindo grade I complications, and 5 (8.1%) late complications in laparoscopy. There were 6 (5.6%) Clavien-Dindo grade I, 3 (2.8%) grade II, 1 (0.9%) grade IV complications and 2 (1.9%) late complications in robotic group.
CONCLUSION: Senhance robot-assisted RP is safe, feasible and offers good and comparable functional and oncological outcomes to laparoscopy. The transition to robotic surgery with a relatively fast learning curve can be done effectively for surgeons with previous laparoscopic experience.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  Senhance; laparoscopic surgery; prostate cancer; radical prostatectomy; robotic surgery

Mesh:

Year:  2021        PMID: 34662926     DOI: 10.1002/rcs.2344

Source DB:  PubMed          Journal:  Int J Med Robot        ISSN: 1478-5951            Impact factor:   2.547


  2 in total

1.  Senhance robot-assisted adrenalectomy: a case series.

Authors:  Nikola Knežević; Luka Penezić; Tomislav Kuliš; Toni Zekulić; Hrvoje Saić; Tvrtko Hudolin; Željko Kaštelan
Journal:  Croat Med J       Date:  2022-04-30       Impact factor: 2.415

2.  Robotic-assisted radical prostatectomy with the Senhance® robotic platform: single center experience.

Authors:  Raimundas Venckus; Marius Jasenas; Titas Telksnys; Martynas Venckus; Vinsas Janusonis; Audrius Dulskas; Narimantas E Samalavicius
Journal:  World J Urol       Date:  2021-07-27       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.